Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men

NCT00448955 is registered in ClinicalTrials.gov with Ardana Bioscience Ltd as lead sponsor.

NCT NCT00448955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00448955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men
Lead sponsor
Ardana Bioscience Ltd
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
February 29, 2008
Enrollment
150 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism